Analyst Ratings for United Therapeutics Corp. (UTHR)
UTHR Rating Summary
UTHR Price Target Summary
- Highest: $850.00 (Cantor Fitzgerald)
- Lowest: $321.00 (Goldman Sachs)
- Average: $653.87
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$653.87 (+11.7%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 65%
Avg. $ Target:
$653.87 (+11.7%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/1/2026 | BTIG | Julian Harrison | Upgrade | Buy (Neutral) |
728.00 (N/A) |
541.89 (585.27) |
8.01% | Details |
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Sell (N/A) |
321.00 (N/A) |
497.59 (585.27) |
17.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
